Introduction: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease whose pattern of weakness is predominantly distal. Limb-girdle muscular dystrophy type 2B/R2-dysferlin-related (LGMD2B/R2) is another neuromuscular disease, which presents an autosomal recessive inheritance and is marked by proximal muscle weakness. Even if uncommon, comorbid inherited pathologies must be considered in cases of atypical presentations, especially in those with family history of consanguinity. Case Presentation: Herein, we report the unique case of a patient diagnosed with both DM1 and LGMD2B/R2: a 38-year-old woman in follow-up of DM1 in a neuromuscular disease service presenting prominent proximal weakness. The patient’s parents were consanguineous, and creatine kinase levels were elevated. A multi-gene panel test was performed and revealed the diagnosis of LGMD2B/R2. Conclusion: Genetic diseases with atypical presentations should raise the possibility of a second disorder, prompting an appropriate investigation. Overlooking a second diagnosis can implicate in not offering adequate genetic counseling, support, or specific treatment.

Journal Section:
Novel Insights from Clinical Practice
Keywords:
Limb-girdle muscular dystrophy, Myotonic dystrophy, Steinert’s disease, Limb-girdle muscular dystrophy type 2B, Dystrophy
1.
Balci TB, Hartley T, Xi Y, Dyment DA, Beaulieu CL, Bernier FP, et al. Debunking Occam’s razor: diagnosing multiple genetic diseases in families by whole-exome sequencing. Clin Genet. 2017;92(3):281–9.
https://doi.org/10.1111/cge.12987
2.
Bockhorst J, Wicklund M. Limb girdle muscular dystrophies. Neurol Clin. 2020;38(3):493–504.
https://doi.org/10.1016/j.ncl.2020.03.009
3.
Carter JC, Sheehan DW, Prochoroff A, Birnkrant DJ. Muscular dystrophies. Clin Chest Med. 2018;39(2):377–89.
https://doi.org/10.1016/j.ccm.2018.01.004
4.
Hannah-Shmouni F, Al-Shahoumi R, Brady LI, Wu L, Frei J, Tarnopolsky MA. Dual molecular diagnoses in a neurometabolic specialty clinic. Am J Med Genet A. 2021;185(3):766–73.
https://doi.org/10.1002/ajmg.a.62034
5.
Iyadurai SJP, Kissel JT. The limb-girdle muscular dystrophies and the dystrophinopathies. Contin Lifelong Learn Neurol. 2016;22(6, Muscle and Neuromuscular Junction Disorders):1954–77.
https://doi.org/10.1212/CON.0000000000000406
6.
Klein A, Clement E, Mercuri E, Muntoni F. Differential diagnosis of congenital muscular dystrophies. Eur J Paediatr Neurol. 2008;12(5):371–7.
https://doi.org/10.1016/j.ejpn.2007.10.002
7.
Lerario A, Colombo I, Milani D, Peverelli L, Villa L, Del Bo R, et al. A case report with the peculiar concomitance of 2 different genetic syndromes. Medicine. 2016;95(49):e5567.
https://doi.org/10.1097/MD.0000000000005567
8.
Locci S, Cardani R, Brunori P, Lucchiari S, Comi GP, Federico A, et al. Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia. Neurol Sci. 2021;42(12):5365–8.
https://doi.org/10.1007/s10072-021-05538-y
9.
Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019;394(10213):2025–38.
https://doi.org/10.1016/S0140-6736(19)32910-1
10.
Smith ED, Blanco K, Sajan SA, Hunter JM, Shinde DN, Wayburn B, et al. A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses. Genet Med. 2019;21(10):2199–207.
https://doi.org/10.1038/s41436-019-0477-2
11.
Starosta RT, Hou Y-CC, Leestma K, Singh P, Viehl L, Manwaring L, et al. Infantile-onset Pompe disease complicated by sickle cell anemia: case report and management considerations. Front Pediatr. 2022;10:944178.
https://doi.org/10.3389/fped.2022.944178
12.
Taghizadeh E, Rezaee M, Barreto GE, Sahebkar A. Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: a review. J Cell Physiol. 2019;234(6):7874–84.
https://doi.org/10.1002/jcp.27907
13.
Turner C, Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry. 2010;81(4):358–67.
https://doi.org/10.1136/jnnp.2008.158261
14.
Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11(10):891–905.
https://doi.org/10.1016/S1474-4422(12)70204-1
15.
Winckler PB, da Silva AMS, Coimbra-Neto AR, Carvalho E, Cavalcanti EBU, Sobreira CFR, et al. Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy. Clin Genet. 2019;96(4):341–53.
https://doi.org/10.1111/cge.13597
16.
Xia Y, Feng Y, Xu L, Chen X, Gao F, Mao S. Case report: whole-exome sequencing with MLPA revealed variants in two genes in a patient with combined manifestations of spinal muscular atrophy and Duchenne muscular dystrophy. Front Genet. 2021;12:605611.
https://doi.org/10.3389/fgene.2021.605611
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.